Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice a change in their breath within the first weeks of starting semaglutide — a slightly bitter, metallic, or "keto-like" odour that wasn't there before. It is a real, documented side effect, not imagined. The causes are mostly dietary and digestive, and most cases settle once the body adjusts. These medicines are prescription-only and are assessed individually for each person, so anything that concerns you mid-treatment is worth raising with your prescriber. Below, we look at the likely reasons this happens and what your options are.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common culprit behind bad breath on semaglutide is a shift in diet rather than the medicine itself acting on the mouth directly. When appetite falls sharply, most people eat significantly fewer carbohydrates, often without planning to. The body responds by burning fat for fuel instead, producing ketones as a by-product. Ketones are exhaled through the lungs, and the result is a sweet, slightly chemical smell, sometimes described as similar to nail varnish remover or overripe fruit. It is the same breath people on very low-calorie or ketogenic diets report.
Semaglutide also delays gastric emptying: food sits in the stomach longer before moving on. That prolonged transit can mean more bacterial fermentation of food residue, and some of those bacterial by-products make their way back up. If you are also experiencing nausea or mild reflux (both listed in the NHS semaglutide medicines guidance as common early effects) that adds another pathway for odour to reach the mouth.
Thinking about what you have been eating since starting treatment often reveals the pattern. Guidance on what to eat on Wegovy can help you find a balanced approach that supports the medicine without tipping you into prolonged ketosis unintentionally.
Semaglutide consistently reduces appetite, and for many people it also reduces thirst. That combination, alongside nausea reducing the appeal of drinks, can lead to mild chronic dehydration without anyone noticing. Saliva is the mouth's natural defence against odour-causing bacteria: it washes debris away, maintains pH, and keeps the mucosal lining healthy. When saliva flow drops, bacteria multiply faster between meals and overnight.
This is one reason semaglutide bad breath is often worst in the morning, overnight fasting is long, saliva production slows during sleep, and if fluid intake has been low during the day, the mouth is already running dry. Sipping water steadily throughout the day is a straightforward first step. Most people find the dehydration-related symptoms improve within a few weeks once they settle into a routine, cleaning teeth after each meal, staying hydrated, and using an alcohol-free mouthwash last thing at night. Chewing sugar-free gum between meals can help stimulate saliva.
If nausea is a significant driver, our page on Wegovy breath covers how GI symptoms and mouth odour connect during the dose-escalation period.
Most cases of bad breath linked to semaglutide resolve on their own, or respond to the practical steps above, within four to eight weeks. The question worth asking yourself is: has the odour been there consistently for more than a few weeks, or has it come with other symptoms, persistent nausea, stomach pain, or significant reflux that is affecting daily life?
If GI symptoms are severe, prolonged, or accompanied by sharp abdominal pain, seek medical advice promptly. The MHRA Drug Safety Updates include guidance on pancreatitis as a rare but serious consideration with GLP-1 medicines: severe, persistent stomach pain that radiates to the back warrants urgent attention, not self-management.
For milder, persistent breath changes that feel out of proportion to the diet explanation, a dentist visit is sensible. Semaglutide does not cause gum disease or tooth decay directly, but dry-mouth effects can create an environment where existing dental issues worsen. Your prescriber can also review whether your dose-titration pace and eating pattern are well matched, sometimes breath symptoms signal the body is adapting and the titration schedule just needs time. If you have questions about whether a persistent symptom is expected, this detailed look at whether semaglutide causes bad breath goes further into the clinical picture.
Some people also find that cutting back on particularly strong-smelling foods helps during the early weeks. Guidance on eating bread on semaglutide and chocolate on Wegovy touches on how specific food choices interact with treatment, useful context if you are trying to work out which elements of your diet are contributing.
If you are mid-treatment and unsure whether what you are experiencing is expected, it is the kind of thing our prescribers hear most weeks, it is worth a quick message rather than sitting with uncertainty. Speak to our prescribers through a free consultation if you are just starting out, or contact the aftercare team if you are already being treated with us.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.